Bai X, Song Y P, Lyu X R, Rao F Y, Qin W, Huang X Y, Li Z X, Liu B H, Jiang Y
School of Public Health, Peking University, Beijing 100191, China.
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Jun 10;40(6):610-615. doi: 10.3760/cma.j.issn.0254-6450.2019.06.002.
To explore the patient and hospital related determinants of adherence to early antithrombotic therapy among patients with acute ischemic stroke (AIS). AIS patients aged 50 years old or above who were eligible for early antithrombotic therapy, were included from the China National Stroke Registry Ⅱ (CNSR Ⅱ) project. Characteristics related to patients and hospitals were collected. Univariate analysis method was conducted to explore the correlation between hospital or patient-related determinants and early antithrombotic therapy. A 2-level logistic regression model was set up to identify patient and hospital-related variables that were associated with the adherence to early antithrombotic therapy, with patient as level 1 and hospital as level 2. A total of 16 910 patients were included in the study, with 14 332 (84.75%) of them having received early antithrombotic therapy. Results from the univariate analysis showed that the patient determinants to early antithrombotic therapy would include age, type of health insurance, average income and history of dyslipidemia. Hospital determinants would include factors as: level and region of the hospital, academic status, with/without stroke unit, quality control on single disease and the percentage of neurological beds in total beds (<0.05). Data on multilevel model showed that the patient-related determinants on early antithrombotic therapy would include age, gender, average income, history of hypertension, National Institutes of Health Stroke Scale (NIHSS) score at admission while hospital related determinants would include percentage of neurological beds in total beds, and region of the hospital (<0.05). The quality of a hospital was associated with the adherence to early antithrombotic therapy. AIS patients at advanced age or with high NIHSS score at admission should be paid more attention.
探索急性缺血性卒中(AIS)患者早期抗栓治疗依从性的患者及医院相关决定因素。纳入中国国家卒中登记Ⅱ(CNSRⅡ)项目中年龄在50岁及以上、符合早期抗栓治疗条件的AIS患者。收集患者及医院的相关特征。采用单因素分析方法探讨医院或患者相关决定因素与早期抗栓治疗之间的相关性。建立二级逻辑回归模型,以识别与早期抗栓治疗依从性相关的患者及医院相关变量,其中患者为一级,医院为二级。本研究共纳入16910例患者,其中14332例(84.75%)接受了早期抗栓治疗。单因素分析结果显示,早期抗栓治疗的患者决定因素包括年龄、医保类型、平均收入和血脂异常病史。医院决定因素包括医院级别和地区、学术地位、有无卒中单元、单病种质量控制以及神经科床位占总床位的百分比(<0.05)。多水平模型数据显示,早期抗栓治疗的患者相关决定因素包括年龄、性别、平均收入、高血压病史、入院时美国国立卫生研究院卒中量表(NIHSS)评分,而医院相关决定因素包括神经科床位占总床位的百分比和医院地区(<0.05)。医院质量与早期抗栓治疗的依从性相关。应更多关注高龄或入院时NIHSS评分高的AIS患者。